Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene.
about
Pulmonary applications and toxicity of engineered nanoparticlesTherapeutic application of RNAi: is mRNA targeting finally ready for prime time?Chymotryptic specificity determinants in the 1.0 A structure of the zinc-inhibited human tissue kallikrein 7Whole blood gene expression in infants with respiratory syncytial virus bronchiolitisInduction of protective effector immunity to prevent pathogenesis caused by the respiratory syncytial virus. Implications on therapy and vaccine designInhibition of Respiratory Syncytial Virus Infections With Morpholino Oligomers in Cell Cultures and in MiceSynthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial VirusSpecificity profiling of seven human tissue kallikreins reveals individual subsite preferencesHuman kallikrein-related peptidase 14 (KLK14) is a new activator component of the KLK proteolytic cascade. Possible function in seminal plasma and skinRespiratory syncytial virus NS1 protein colocalizes with mitochondrial antiviral signaling protein MAVS following infectionMicroRNA regulation of human protease genes essential for influenza virus replicationRNA interference for alpha-ENaC inhibits rat lung fluid absorption in vivo12R-lipoxygenase deficiency disrupts epidermal barrier functionImpaired spermatogenesis and fertility in mice carrying a mutation in the Spink2 gene expressed predominantly in testesThe interactome of the human respiratory syncytial virus NS1 protein highlights multiple effects on host cell biologyNanodelivery in airway diseases: challenges and therapeutic applications.Kallikrein-related peptidase-8 (KLK8) is an active serine protease in human epidermis and sweat and is involved in a skin barrier proteolytic cascade.Pharmacologic advances in the treatment and prevention of respiratory syncytial virus.Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsivenessRespiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte responseActivity and regulation of alpha interferon in respiratory syncytial virus and human metapneumovirus experimental infections.Involvement of activation of PKR in HBx-siRNA-mediated innate immune effects on HBV inhibition.Development of PEGylated PLGA nanoparticle for controlled and sustained drug delivery in cystic fibrosisLive-cell characterization and analysis of a clinical isolate of bovine respiratory syncytial virus, using molecular beacons.The infectious march: the complex interaction between microbes and the immune system in asthma.Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo.Plasmid-encoded NP73-102 modulates atrial natriuretic peptide receptor signaling and plays a critical role in inducing tolerogenic dendritic cells.Kallikrein-5 promotes cleavage of desmoglein-1 and loss of cell-cell cohesion in oral squamous cell carcinoma.Combined fluticasone propionate and salmeterol reduces RSV infection more effectively than either of them alone in allergen-sensitized mice.Hair follicular expression and function of group X secreted phospholipase A2 in mouse skin.Possibilities for RNA interference in developing hepatitis C virus therapeutics.Progress in understanding and controlling respiratory syncytial virus: still crazy after all these yearsChitosan-DNA nanoparticles delivered by intrabiliary infusion enhance liver-targeted gene deliveryProtein-Protein Interactions of Viroporins in Coronaviruses and Paramyxoviruses: New Targets for Antivirals?Nanotechnology Applications to HIV Vaccines and Microbicides.Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes.siRNA against the G gene of human metapneumovirus.Efficient inhibition of HIV-1 replication by an artificial polycistronic miRNA construct.Information technologies for vaccine research.Respiratory Syncytial Virus Nonstructural Proteins Upregulate SOCS1 and SOCS3 in the Different Manner from Endogenous IFN Signaling.
P2860
Q24650775-4E465DD4-3A1E-4D58-8A6B-6FEE67E98089Q24669624-05F1B419-4630-439C-9528-A63D087E5059Q24674282-3F3D8771-3383-43EF-8F3C-7B5CD85086A3Q24679785-3630E855-6E17-43E6-ACBC-672203D051F6Q27021304-1896A362-9E30-4E43-9CC9-6D1AA496261AQ27490424-D5B23CEC-BC43-4A59-900A-CED787ACE7E7Q28067143-9F71BE43-E51F-46D1-8F0F-B4F941CC6F7BQ28243373-E4D642F3-596A-4129-9A8E-ACF3B52FD147Q28259758-54D5C917-179C-4536-90DA-D25CF449E07CQ28481271-06C0C7D5-500B-4461-8FA7-0E69D1EFD743Q28483683-7E6B9D95-68CA-424D-A424-6A7808BEBB35Q28572413-A8B48CAC-300B-4E93-A59A-CFE1D1BB7EA9Q28585387-EF5A0D8F-C941-4DBB-AD59-346F4158CDBAQ28593778-85DC5476-54A5-4738-9516-22881B5423BFQ28728377-D1C545A2-E273-4C12-9B4D-6B37BB53F4EAQ33483926-07FDB6C7-90DC-40E1-A886-95C7FA48A174Q33715944-7AD2C48C-D507-4BB7-B447-066FF0A8C349Q33776507-DD50959C-CA26-4B34-A95F-E4619DB9644BQ33883942-FC72E5C2-E235-4D11-ADD1-8791FD434446Q33886159-6599FD1C-C505-4418-90A5-EBC348A84AA8Q33911955-72A0B41A-D267-478B-B7B9-70736348BB6BQ34102905-CB5EB01B-FA26-490B-B500-347E3C2DC9A0Q34198852-C4FAFDB9-D5DB-43AA-AF7B-223C63D13DAEQ34301714-498B92A3-4CBF-4930-BE05-3E59C8B0E89BQ34356430-5986594D-122D-4AA1-A8CC-091A1BEC85C6Q34496721-D8D97F83-BEAF-49A8-B851-478E8DC55BDCQ34515184-76ADB9C0-7603-448C-87F6-57B1C2FF0A01Q34685425-6428C731-79C6-43CC-B472-1E70C35A90BCQ34715945-9752C7D9-35B3-4CF7-974E-B6CE29C11A52Q34719753-394F2AEC-29AE-48C0-990B-9415CF37E457Q35261143-7BFF0E59-E6AA-4ED2-8A1C-50A30404EC51Q35566601-F5B5BB82-2C25-4A47-BD2A-BC7A6433F25AQ35688220-20C5B487-8D15-40F6-8E61-924B9EC30340Q35808644-C8C49038-E65B-44F7-BB85-333C154F32A6Q35890514-F8CDC3EA-A905-4536-98BC-EE1C9B677B7BQ35928850-9E0A3282-9F97-41D9-8D99-EA9B7A4CE446Q36086887-56ED1150-1E9C-4FE4-BD97-F3C1B41C7160Q36156552-3EE52832-E321-48E4-A8B3-394360374416Q36198676-84F05892-DAE6-4C7A-A150-4395AD413336Q36236235-4381EB6F-2566-439C-8274-FAB776FD8EAA
P2860
Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Inhibition of respiratory sync ...... targeting the viral NS1 gene.
@en
Inhibition of respiratory sync ...... targeting the viral NS1 gene.
@nl
type
label
Inhibition of respiratory sync ...... targeting the viral NS1 gene.
@en
Inhibition of respiratory sync ...... targeting the viral NS1 gene.
@nl
prefLabel
Inhibition of respiratory sync ...... targeting the viral NS1 gene.
@en
Inhibition of respiratory sync ...... targeting the viral NS1 gene.
@nl
P2093
P2860
P356
P1433
P1476
Inhibition of respiratory sync ...... targeting the viral NS1 gene.
@en
P2093
Gary Hellermann
Homero San Juan-Vergara
Rajeswari Singam
Richard F Lockey
Shyam S Mohapatra
Subhra Mohapatra
Sumita Behera
Weidong Zhang
Xiaoyuan Kong
P2860
P2888
P356
10.1038/NM1174
P407
P577
2004-12-26T00:00:00Z
P5875
P6179
1042953105